A New Intercepted Miniseries on the Supreme Court

In the first episode of Dissent, host Jordan Smith and legal analyst Jordan Rubin discuss the Supreme Court docket and what’s at stake.

MOST READ

Unredacted NIH Emails Show Efforts to Rule Out Lab Origin of Covid

Jimmy Tobias

Virologists close to the NIH initially believed the Covid virus could be genetically engineered. Unredacted emails show how their thinking evolved.

READ MORE →

 

Covid-19 Drugmakers Pressured Twitter to Censor Activists Pushing for Generic Vaccine

Lee Fang

The social media pressure campaign was just a part of the pharmaceutical industry’s successful lobbying blitz to retain patents — and make record profits.

READ MORE →

 

Protecting freedom of the press has never been more important. Be the next person to support The Intercept’s independent journalism by becoming a member today.

BECOME A MEMBER →


Top Stories

Mexico’s Former Top Cop Is on Trial in New York. Will the U.S. Be Implicated?

José Olivares

Genaro García Luna, a drug war insider facing charges of colluding with two major cartels, was in a position to collect dirt on officials on both sides of the border.

READ MORE →

 

LAPD Held Down Keenan Anderson, Repeatedly Tased Him — Then Suggested His Death Was His Own Fault

Natasha Lennard

That the LAPD is confidently deploying this public relations tactic nearly three years after George Floyd’s death is a grim reflection of how little has changed.

READ MORE →

 

California Police Are Buying Guns From Dealers With Troubling Records

Jordan Smith

Law enforcement agencies spent millions in taxpayer funds buying weapons from vendors cited for gun safety violations, a new analysis reveals.

READ MORE →

 

Empire by Invitation

Samar Al-Bulushi

African leaders are asking for more U.S. counterterrorism support. They should be careful what they wish for.

READ MORE →

 


Podcasts

 

Dissent Episode One: Tipping the Balance

Intercepted

In the first episode of Dissent, host Jordan Smith and legal analyst Jordan Rubin discuss the Supreme Court docket and what’s at stake.

LISTEN →

 

Key phrases

Older messages

The GOP’s Kevin McCarthy Debacle Is an Insurrection by Other Means

Monday, January 9, 2023

Two years after January 6, Republicans are still locked in a battle for personal political power. MOST READ The GOP's Kevin McCarthy Debacle Is an Insurrection by Other Means James Risen Two years

What Matt Gaetz and AOC Talked About During Kevin McCarthy’s Speaker Vote

Thursday, January 5, 2023

Alexandria Ocasio-Cortez said Matt Gaetz wanted to know if Democrats would bail out the would-be Republican speaker. Not a chance, she told him. MOST READ How Jan. 6 Brought Frontier Violence to the

Hacked Russian Files Reveal Propaganda Agreement With China

Monday, January 2, 2023

In 2021, government officials and media executives from Russia and China discussed the exchange of news and social content. MOST READ Hacked Russian Files Reveal Propaganda Agreement With China Mara

Less than 8 hours left. This goal really matters.

Saturday, December 31, 2022

To continue our ambitious reporting we still need to raise $40000 by midnight. Your donation will help us expose political and corporate corruption in 2023 and beyond. Today is New Year's Eve. We

This is where the rubber hits the road

Saturday, December 31, 2022

We still have $60000 left to raise before tonight's deadline. Will you help get us over the top? The Intercept was launched with the bold — some would say crazy — idea that world-class

You Might Also Like

How to build a “Bloomberg for X” media company

Thursday, April 25, 2024

Many companies that attempted to monetize media outlets with non-media tech products have stumbled. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Prefer to Skip Mother’s Day Emails?

Thursday, April 25, 2024

Tap a button, and you won't hear from us. The Strategist Prefer to Skip Mother's Day Emails? Mother's Day is coming up, and we understand that this can be a difficult time for some. So if

GeekWire Mid-Week Update

Wednesday, April 24, 2024

Read the top tech stories so far this week from GeekWire GeekWire Mid-Week Update Top stories so far this week After lobbying by Uber and DoorDash, new proposal would overhaul Seattle's minimum

Student Protesters Are Schooling Their Universities

Wednesday, April 24, 2024

Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer student protests Student Protesters Are Schooling Their Universities Pro-Palestinian

The magic of white noise

Wednesday, April 24, 2024

Sweet dreams ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Thursday Briefing: Israel seems poised to invade Rafah

Wednesday, April 24, 2024

Also, details of the US aid package to Ukraine and Taylor Swift's new album View in browser|nytimes.com Continue reading the main story Ad Morning Briefing: Asia Pacific Edition April 25, 2024

Feeling stressed? This doctor’s got a book on it.

Wednesday, April 24, 2024

You're invited to The Conversation's book club in May ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

ByteDance with Death

Wednesday, April 24, 2024

TikTok's Tick Tock, Calorie Restriction ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

The Rise Of Big Oil’s Zombie Pipelines

Wednesday, April 24, 2024

Big Oil is fighting to limit safety protections to expedite its build-out of experimental carbon dioxide pipelines, endangering nearby communities. While leaks from carbon dioxide pipelines have sent

How the FTC ban on non-competes could help tech companies

Wednesday, April 24, 2024

Microsoft earnings preview | 98point6 layoffs | New EV rebate program ADVERTISEMENT GeekWire SPONSOR MESSAGE: Science Firsthand: Learn how Bristol Myers Squibb unlocked the potential of CAR T cell